FdaApplication
ANDA 208829
Identifiers
- fda_app_no: ANDA208829
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS CO GMBH |
| application_type | ANDA |
| approval_date | 2017-05-24 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET;ORAL |
5 products